Spyre Therapeutics, Inc SYRE 深 沪
等待开盘 08-10 09:30:00 美东时间
104.91
+1.490
+1.44%
华盛通- 最 高108.14
- 今 开106.01
- 成交量 51.69万股
- 最 低 97.03
- 昨 收 103.42
- 总市值 0
- 52周最高 108.14
- 市盈率 静 --
- 换手率 Infinity.00%
- 52周最低 14.505
- 委 比 -98.20%
- 总股本 --
- 历史最高 108.14
- 量 比 0.74
- 振 幅 10.74%
- 历史最低 0.02
- 每 手 1
- 风险率 27.57%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Wolfe Research Downgrades Spyre Therapeutics to Peer Perform
Wolfe Research analyst Andy Chen downgrades Spyre Therapeutics (NASDAQ:SYRE) from Outperform to Peer Perform.
07-29 00:17
Spyre Therapeutics Expands SPY003 Rights Beyond IBD Through Amended Paragon License Agreement
On May 29, 2026, the Company entered into the First Amendment to Amended and Restated License Agreement (the "Amendment"), amending the Amended and Restated License Agreement dated as of February 24, 2025 (as amended,
06-02 04:11
12 Health Care Stocks Moving In Monday's Pre-Market Session
Gainers Virax Biolabs Group (NASDAQ:VRAX) stock increased by 76.7% to $0.18 du...
04-13 20:05
Earnings Summary: Spyre Therapeutics Q4
Spyre Therapeutics (NASDAQ:SYRE) announced its Q4 earnings on Thursday, Februar...
02-20 05:32
This Chevron Analyst Turns Bullish; Here Are Top 5 Upgrades For Monday
Top Wall Street analysts changed their outlook on these top names. For a comple...
2025-12-01 22:01
凯雷Q1坚定押注StandardAero(SARO.US) 清仓Robinhood(HOOD.US)
根据美国证券交易委员会(SEC)披露，全球另类资产管理巨头凯雷(CARLYLE GROUP INC)递交了截止至2025年3月31日的第一季度持仓报告(13F...
2025-05-16 17:23
Wedbush Initiates Spyre Therapeutics at Outperform With $45 Price Target
06:24 AM EDT, 09/04/2024 (MT Newswires) -- Spyre Therapeutics (SYRE) has an average buy rating and a price target range of $40 to $54, according to analysts polled by Capital IQ. (MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia a...
2024-09-04 18:24
